Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2024 Jul 22;9(7):903-905.
doi: 10.1016/j.jacbts.2024.05.009. eCollection 2024 Jul.

Selective Inhibition of Peripheral Serotonin Synthesis in Pulmonary Hypertension

Olympia Bikou  1 , Katrin Schäfer  2
Affiliations
Editorial

Selective Inhibition of Peripheral Serotonin Synthesis in Pulmonary Hypertension

Olympia Bikou et al. JACC Basic Transl Sci. .
No abstract available

Keywords: Sugen; hypoxia; pulmonary hypertension; rat model; right heart failure; serotonin; therapy; tryptophan hydroxylase 1.

PubMed Disclaimer

Conflict of interest statement

This study was supported by research funding from the German Research Foundation (Deutsche Forschungsgemeinschaft; SCHA 808/9-2 and 15-1) and the Collaborative Research Center (1531, project A09; project number 456687919). Dr Schäfer is Principal Investigator of the German Center for Cardiovascular Research (DZHK), partner site Rhine-Main. Dr Bikou is a DZHK Scientist, partner site Munich Heart Alliance.

Figures

None
Graphical abstract
None
Graphical abstract
See this image and copyright information in PMC

Comment on

  • doi: 10.1016/j.jacbts.2024.04.006

Similar articles

See all similar articles

References

    1. Ruopp N.F., Cockrill B.A. Diagnosis and treatment of pulmonary arterial hypertension: a review. JAMA. 2022;327(14):1379–1391. - PubMed
    1. Humbert M., Kovacs G., Hoeper M.M., et al. 2022 ESC/ERS guidelines for the diagnosis and treatment of pulmonary hypertension. Eur Heart J. 2022;43(38):3618–3731. - PubMed
    1. Hoeper M.M., Badesch D.B., Ghofrani H.A., et al. Phase 3 trial of sotatercept for treatment of pulmonary arterial hypertension. N Engl J Med. 2023;388(16):1478–1490. - PubMed
    1. Simonneau G., Fartoukh M., Sitbon O., Humbert M., Jagot J.L., Hervé P. Primary pulmonary hypertension associated with the use of fenfluramine derivatives. Chest. 1998;114(3 Suppl):195s–199s. - PubMed
    1. Abenhaim L., Moride Y., Brenot F., Rich S., Benichou J., Kurz X., et al. Appetite-suppressant drugs and the risk of primary pulmonary hypertension. International Primary Pulmonary Hypertension Study Group. N Engl J Med. 1996;335(9):609–616. - PubMed

Publication types

LinkOut - more resources